Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson's Disease Using the Food and Drug Administration Adverse Event Reporting System.
Psychopharmacology bulletin · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
Parkinson diseaseDopamine agonistsPharmacovigilanceRopiniroleImpulse Control DisorderPramipexoleRotigotineHumansParkinson DiseaseThiophenesIndolesTetrahydronaphthalenesDopamine AgonistsRetrospective StudiesAdverse Drug Reaction Reporting SystemsMental DisordersUnited States Food and Drug AdministrationAgedMiddle AgedUnited StatesFemaleMaledopamine agonistsimpulse control disorderparkinson diseasepharmacovigilancepramipexoleropinirolerotigotine
Come citare questo studio
Ogura T, Shiraishi C. (2026). Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson's Disease Using the Food and Drug Administration Adverse Event Reporting System.. Psychopharmacology bulletin. DOI: 10.64719/pb.21621
Consulta la pubblicazione originale ↗